119 related articles for article (PubMed ID: 35718982)
1. Dysregulated YAP1/Hippo Pathway Contributes to Doxorubicin (ADM) Resistance in Acute Myeloid Leukemia (AML).
Song Y; Chen X; Huang R; Liu J
Curr Pharm Biotechnol; 2023; 24(5):676-685. PubMed ID: 35718982
[TBL] [Abstract][Full Text] [Related]
2. CircPAN3 contributes to drug resistance in acute myeloid leukemia through regulation of autophagy.
Shang J; Chen WM; Liu S; Wang ZH; Wei TN; Chen ZZ; Wu WB
Leuk Res; 2019 Oct; 85():106198. PubMed ID: 31401408
[TBL] [Abstract][Full Text] [Related]
3. CircPAN3 mediates drug resistance in acute myeloid leukemia through the miR-153-5p/miR-183-5p-XIAP axis.
Shang J; Chen WM; Wang ZH; Wei TN; Chen ZZ; Wu WB
Exp Hematol; 2019 Feb; 70():42-54.e3. PubMed ID: 30395908
[TBL] [Abstract][Full Text] [Related]
4. HOTAIR suppresses PTEN via DNMT3b and confers drug resistance in acute myeloid leukemia.
Zhou W; Xu S; Chen X; Wang C
Hematology; 2021 Dec; 26(1):170-178. PubMed ID: 33538241
[TBL] [Abstract][Full Text] [Related]
5. [MiR-199a-5p Affects Sensitivity of Acute Myeloid Leukemia to Adriamycin by Targeting DRAM1].
Li Y; Sun Y; Miao M; Shi X; Yang W; Liu ZG
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Aug; 28(4):1096-1104. PubMed ID: 32798383
[TBL] [Abstract][Full Text] [Related]
6. TET1-mediated microRNA-188-5p promoter hydroxymethylation regulates PTEN/PI3K/AKT signaling pathway in acute myeloid leukemia cells.
Lu N; Wang X; Wang W; Tang M; Chen J; You H; Wang D
Arch Biochem Biophys; 2023 Mar; 736():109523. PubMed ID: 36682704
[TBL] [Abstract][Full Text] [Related]
7. Knockdown of CD44 enhances chemosensitivity of acute myeloid leukemia cells to ADM and Ara-C.
Wang NS; Wei M; Ma WL; Meng W; Zheng WL
Tumour Biol; 2014 Apr; 35(4):3933-40. PubMed ID: 24375249
[TBL] [Abstract][Full Text] [Related]
8. Disruption of the Hippo pathway promotes the proliferation of childhood acute lymphoblastic leukemia cells, inhibits apoptosis and chemosensitivity.
Jiang H; Zhang RB; Peng J; Ren L; Wang HD
Expert Rev Hematol; 2024 Jun; 17(6):269-274. PubMed ID: 38753450
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-103 confers the resistance to long-treatment of adriamycin to human leukemia cells by regulation of COP1.
Wan L; Tian Y; Zhang R; Peng Z; Sun J; Zhang W
J Cell Biochem; 2018 May; 119(5):3843-3852. PubMed ID: 29058777
[TBL] [Abstract][Full Text] [Related]
10. Histone deacetylase 1 induced by neddylation inhibition contributes to drug resistance in acute myelogenous leukemia.
Lai QY; He YZ; Peng XW; Zhou X; Liang D; Wang L
Cell Commun Signal; 2019 Jul; 17(1):86. PubMed ID: 31358016
[TBL] [Abstract][Full Text] [Related]
11. LncRNA-PAX8-AS1 Silencing Decreases Cell Viability, Enhances Apoptosis, and Suppresses Doxorubicin Resistance in Myeloid Leukemia via the miR-378g/ERBB2 Axis.
Song X; Chen Y; Peng Y; Wang X; Zheng S; Shi F; Lan J
Evid Based Complement Alternat Med; 2022; 2022():2295044. PubMed ID: 36248434
[TBL] [Abstract][Full Text] [Related]
12. Resveratrol-mediated reversal of doxorubicin resistance in acute myeloid leukemia cells via downregulation of MRP1 expression.
Kweon SH; Song JH; Kim TS
Biochem Biophys Res Commun; 2010 Apr; 395(1):104-10. PubMed ID: 20350534
[TBL] [Abstract][Full Text] [Related]
13. LncRNA KCNQ1OT1 contributes to the progression and chemoresistance in acute myeloid leukemia by modulating Tspan3 through suppressing miR-193a-3p.
Sun H; Sun Y; Chen Q; Xu Z
Life Sci; 2020 Jan; 241():117161. PubMed ID: 31837329
[TBL] [Abstract][Full Text] [Related]
14. Effect of phosphatase and tensin homology deleted on chromosome 10 (PTEN) gene transfection on reversal of multidrug resistance in K562/ADM cells.
Cheng Z; Yang N; Liang W; Yan X; Li L; Pan L
Leuk Lymphoma; 2012 Jul; 53(7):1383-9. PubMed ID: 22185283
[TBL] [Abstract][Full Text] [Related]
15. Yes-associated protein 1 exerts its tumor-promoting effects and increases cisplatin resistance in tongue squamous cell carcinoma cells by dysregulating Hippo signal pathway.
Guan H; Deng L
Anticancer Drugs; 2022 Apr; 33(4):352-361. PubMed ID: 35266885
[TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA SNHG5 regulates chemotherapy resistance through the miR-32/DNAJB9 axis in acute myeloid leukemia.
Wang D; Zeng T; Lin Z; Yan L; Wang F; Tang L; Wang L; Tang D; Chen P; Yang M
Biomed Pharmacother; 2020 Mar; 123():109802. PubMed ID: 31884339
[TBL] [Abstract][Full Text] [Related]
17. miR-590-5p suppresses hepatocellular carcinoma chemoresistance by targeting YAP1 expression.
Chen M; Wu L; Tu J; Zhao Z; Fan X; Mao J; Weng Q; Wu X; Huang L; Xu M; Ji J
EBioMedicine; 2018 Sep; 35():142-154. PubMed ID: 30111512
[TBL] [Abstract][Full Text] [Related]
18. Cyclosporine diminishes multidrug resistance in K562/ADM cells and improves complete remission in patients with acute myeloid leukemia.
Li GY; Liu JZ; Zhang B; Wang LX; Wang CB; Chen SG
Biomed Pharmacother; 2009 Sep; 63(8):566-70. PubMed ID: 19095404
[TBL] [Abstract][Full Text] [Related]
19. TRIB2 knockdown as a regulator of chemotherapy resistance and proliferation via the ERK/STAT3 signaling pathway in human chronic myelogenous leukemia K562/ADM cells.
Ma X; Zhou X; Qu H; Ma Y; Yue Z; Shang W; Wang P; Xie S; Li Y; Sun Y
Oncol Rep; 2018 Apr; 39(4):1910-1918. PubMed ID: 29436678
[TBL] [Abstract][Full Text] [Related]
20. Knockdown of LncRNA CRNDE suppresses proliferation and P-glycoprotein-mediated multidrug resistance in acute myelocytic leukemia through the Wnt/β-catenin pathway.
Kang Y; Zhang S; Cao W; Wan D; Sun L
Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32426817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]